Keith Miller

Dr. Keith Miller

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2003 in Drug Resistance Updates
Verified
Journal Article
Closed access
ICIan Chopra
Ian Chopra
AOAlexander J O’nEill
Alexander J O’nEill
KMKeith Miller
Keith Miller

6 February 2008 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
KDK. Driffield
K. Driffield
KMKeith Miller
Keith Miller
JBJ. M. Bostock
J. M. Bostock
AOA. J. O'NEill
A. J. O'NEill
ICI. Chopra
I. Chopra
Isolates of Pseudomonas aeruginosa from cystic fibrosis (CF) patients are frequently hypermutable due to selection of mutants with defects in DNA repair genes such as mutS. Since P. aeruginosa grows as a biofilm within the infected CF lung, it is possible that this mode of growth enhances the mutability of the organism thereby increasing the opportunity to derive permanent hypermutators through mutation in DNA repair genes. We have now conducted experiments to examine this possibility. Using established procedures, we examined the mutability of P. aeruginosa PA01 in planktonic cultures and in biofilm cultures generated by growth in a Sorbarod system. Transcriptional profiling by DNA microarray was used to compare gene expression in planktonic and biofilm cells. Mutation frequency determinations for resistance to rifampicin and ciprofloxacin demonstrated that biofilm cultures of P. aeruginosa displayed up to a 105-fold increase in mutability compared with planktonic cultures. Several genes (ahpC, katA, sodB and PA3529, a probable peroxidase) that encode enzymes conferring protection against oxidative DNA damage were down-regulated in biofilm cells. In particular, katA, which encodes the major pseudomonal antioxidant catalase, was down-regulated 7.7-fold. Down-regulation of antioxidant enzymes in P. aeruginosa biofilms may enhance the rate of mutagenic events due to the accumulation of DNA damage. Since P. aeruginosa forms biofilms in the CF lung, this mode of growth may enhance the direct selection of antibiotic-resistant organisms in CF patients and also increase the opportunity to derive permanent hypermutators thereby providing a further source of antibiotic-resistant mutants in the CF lung.

1 February 2008 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
ICIan Chopra
Ian Chopra
CSChristopher Schofield
Christopher Schofield
MEMartin Everett
Martin Everett
AOAlex O'NEill
Alex O'NEill
KMKeith Miller
Keith Miller
PCPatrice Courvalin
Patrice Courvalin

1 September 2014 in Toxicon
Verified
Journal Article
Closed access
PHPatrick L. Harrison
Patrick L. Harrison
MAMohamed A. Abdel-Rahman
Mohamed A. Abdel-Rahman
KMKeith Miller
Keith Miller
PSPeter N. Strong
Peter N. Strong

18 July 2008 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
JHJoanne Hobbs
Joanne Hobbs
KMKeith Miller
Keith Miller
AOAlex John O’neill
Alex John O’neill
ICIan Chopra
Ian Chopra
The proposed lethal action of daptomycin on Staphylococcusaureus results from the loss of K+ and membrane depolarization. However, whether these events alone cause cell death has been questioned. We sought to determine whether other consequences of daptomycin-mediated membrane damage may contribute to cell death. Previously established assays were used to evaluate the membrane damaging activity of daptomycin at a single time-point of 10 min. More detailed time-course experiments were also performed to determine the kinetics of membrane depolarization and leakage of K+, Mg2+ and ATP. The kinetics of inhibition of macromolecular synthesis following exposure to daptomycin were also determined by assaying the incorporation of radioactive precursors into macromolecules. Daptomycin exhibited no membrane damaging activity in single time-point assays following exposure to the antibiotic for 10 min. Kinetic analysis confirmed these results as leakage of intracellular components did not occur until 20–30 min, membrane depolarization was gradual and cells remained biosynthetically active for at least 30 min after exposure to daptomycin. Viability declined rapidly after exposure to daptomycin and appeared to precede other detectable changes. These data show that daptomycin-induced loss of Mg2+ and ATP occurs in conjunction with the previously reported leakage of K+ and membrane depolarization. We propose that the lethal activity of daptomycin is not simply due to loss of K+ and probably involves more general damage to the membrane.

4 November 2009 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
NONicola Ooi
Nicola Ooi
KMKeith Miller
Keith Miller
CRChristopher Randall
Christopher Randall
WRWilliam Rhys-Williams
William Rhys-Williams
WLWilliam Love
William Love
ICIan Chopra
Ian Chopra
Slow-growing and non-dividing bacteria exhibit tolerance to many antibiotics. However, membrane-active agents may act against bacteria in all growth phases. We sought to examine whether the novel porphyrin antibacterial agents XF-70 and XF-73, which have rapid membrane-perturbing activity against Staphylococcus aureus, retained antistaphylococcal activity against growth-attenuated cells. The killing kinetics of XF-70, XF-73 and various comparator agents against exponential phase cultures of S. aureus SH1000 were compared with effects on cells held at 4°C, non-growing cultures expressing the stringent response induced by mupirocin and bacteria in the stationary phase. Biofilms of S. aureus SH1000 were generated with the Calgary device to examine the activities of XF-70 and XF-73 under a further system exhibiting diminished bacterial growth. Cold culture, stringent response and stationary phase cultures remained susceptible to XF-70 and XF-73, which caused ≥5 log reductions in viability over 2 h. During this period the most active comparator agents (chlorhexidine and cetyltrimethylammonium bromide) only promoted a 3 log drop in viability. XF-70 and XF-73 were also highly active against biofilms, with both agents exhibiting low biofilm MICs (1 mg/L) and minimum biofilm eradication concentrations (2 mg/L). XF-70 and XF-73 remained highly active against various forms of slow-growing or non-dividing S. aureus. The results support the hypothesis that membrane-active agents may be particularly effective in eradicating slow- or non-growing bacteria and suggest that XF-70 and XF-73 could be utilized to treat staphylococcal infections where the organisms are only dividing slowly, such as biofilm-associated infections of prosthetic devices.